Silvia Moimas
Trieste, 34139, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Epigenetic Drugs Splitomicin, Suberohydroxamic Acid, CPTH6, BVT-948, and PBIT Moderate Fibro-Fatty Development in Arrhythmogenic Cardiomyopathy.
Journal: Biomolecules
Published: October 03, 2025
Author Correction: A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration.
Journal: Nature communications
Published: August 25, 2022
Anisotropic topographies restore endothelial monolayer integrity and promote the proliferation of senescent endothelial cells.
Journal: Frontiers in cardiovascular medicine
Published: May 26, 2022
Mechanical Fingerprint of Senescence in Endothelial Cells.
Journal: Nano letters
Published: June 03, 2021
Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction.
Journal: Nature communications
Published: January 07, 2021
A free-form patterning method enabling endothelialization under dynamic flow.
Journal: Biomaterials
Published: August 26, 2020
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation.
Journal: ERJ open research
Published: June 05, 2019
Supporting data on in vitro cardioprotective and proliferative paracrine effects by the human amniotic fluid stem cell secretome.
Journal: Data in brief
Published: May 06, 2019
Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome.
Journal: International journal of cardiology
Published: May 30, 2018
A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration.
Journal: Nature communications
Published: August 10, 2017
Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction.
Journal: Nature communications
Published: July 13, 2017
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy.
Journal: Scientific reports
Published: December 13, 2016
Last Updated: 09/26/2026